Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
1.980
-0.090 (-4.35%)
Oct 22, 2026, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $88.73 million as of October 22, 2026. It is the 25,935th most valuable company in the world and the 4,175th biggest in the United States. Its market cap has decreased by 64.64% in one year.
Market Cap
88.73M
Enterprise Value
72.48M
1-Year Change
-64.64%
Global Rank
Country Rank
#4,175 United States
Category
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $88.73M, a decrease of -37.38%. That is a compound annual growth rate of -11.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 88.73M | -45.90% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 119.96M |
| Minerva Neurosciences | 119.85M |
| Black Diamond Therapeutics | 119.22M |
| enGene Therapeutics | 113.93M |
| TuHURA Biosciences | 112.80M |
| Seer, Inc. | 112.41M |
| Humacyte | 111.48M |
| NRx Pharmaceuticals | 111.19M |